GlassScriptPhysician profile
James Anthony Raley
NPI 1033592704
$13,247.62
in general payments reported to CMS, 2019-2025
14 companies · $785 in 2025
The $785 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,413 · 2020: $326 · 2021: $928 · 2022: $1,040 · 2023: $465 · 2024: $8,289 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,440 · Food and Beverage: $1,240 · Travel and Lodging: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,440.00 |
| Food and Beverage | $1,239.70 |
| Travel and Lodging | $859.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $8,440.25 | 2021-2024 | Attune, Velys, Actis |
| Smith+Nephew, INC. | $1,560.48 | 2020-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Trigen Intertan, Evos |
| Depuy Synthes Sales INC. | $1,133.89 | 2019-2025 | Velys, Na, Orthovisc |
| Zimmer Biomet Holdings, INC. | $973.64 | 2019-2021 | |
| Medacta USA, INC. | $457.61 | 2022-2023 | Gmk Sphere |
| Stryker Corporation | $308.96 | 2019-2022 | |
| Kci USA, INC. | $110.62 | 2023 | Prevena |
| Allergan, INC. | $105.20 | 2019 | |
| Next Science LLC | $57.13 | 2021 | |
| Convatec INC. | $24.47 | 2025 | |
| Pacira Therapeutics, INC. | $22.92 | 2021 | |
| Arthrosurface Incorporated | $21.62 | 2019 | |
| Nuvasive, INC. | $19.14 | 2020 | |
| Bioventus LLC | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Raley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.